Objectives As access to antiretrovirals (ARV) increases in developing countries, the identification of optimal therapeutic regimens and prevention strategies requires the identification of resistance pathways in non-B subtypes as well as the surveillance of drug mutation resistance (SDMR) including the trafficking of viral strains between high-risk groups such as commercial sex workers (CSW) and the general population (GP). In this study, the authors evaluated the rate of primary resistance mutations and the epidemiological link between isolates from GP and CSW from Bénin. Methods Plasma samples were obtained from 129 HIV-1-infected treatment-naı̈ve individuals. Drug resistance mutations were identified using SDMR list and compare
To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.